Article
Analysis of molecular aberrations in ovarian cancer allows novel target identification.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC - 1 May 2004
Cheng Kwai Wa, Lahad John P, Mills Gordon B
Abstract excerpt
The completion of the Human Genome Project and recent advances in functional genomic, proteomic, and high-throughput screening methodologies have provided powerful tools for determining the mechanisms of human diseases, including complex polygenic diseases such as ovarian cancer. These developments may eventually lead to individualized molecular medicine, which is the treatment of patients based on the underlying...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
